Related Experiment Videos
Successful treatment of malignant carcinoid tumour with intravenous cis-platinum
1Department of Radiotherapy and Oncology, Norfolk and Norwich Hospital.
Abstract:
A case of carcinoid tumour responding to i.v. Cis-Platinum is described. These results suggest that this agent may be effective in treating this condition and further evaluation in a larger number of patients should be performed.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Prostate cancer DNA ploidy and response to salvage hormone therapy after radiotherapy with or without short-term total androgen blockade: an analysis of RTOG 8610.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2003
Neoadjuvant estramustine and etoposide followed by concurrent estramustine and definitive radiotherapy for locally advanced prostate cancer: feasibility and preliminary results.
International journal of radiation oncology, biology, physics·2001
Modeling of internal dose distributions during SR-89 treatment of a patient with bone metastases.
Cancer biotherapy & radiopharmaceuticals·2000
The impact of race on biochemical disease-free survival in early-stage prostate cancer patients treated with surgery or radiation therapy.
International journal of radiation oncology, biology, physics·1999
Epidemiology of resected colorectal liver metastasis and use of perioperative chemotherapy: a prospective cohort study on the impact of next generation sequencing and mutation profiling in a real-world population.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2026
Machine learning-based model for predicting post-operative complications and evaluating long-term survival in elderly patients undergoing VATS for early-stage lung adenocarcinoma.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2026
The impact of the Integrated Oncological Decision-Making Model (IODM) on healthcare costs and health outcomes in older patients with lower gastrointestinal tumors.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2026
Patient selection in those undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases - systematic review and meta-analysis of prognostic factors in large cohorts.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2026
Impact of pathological fracture on outcomes after surgery for metastatic femoral bone tumors: A multi-institutional study by the Tokai Musculoskeletal Tumor Consortium.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2026
Comparing ECOG-PS and Charlson Comorbidity Index for stratification of hepatocellular carcinoma prognosis across treatments.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2026
From Phase Ib/II to Seamless Phase II/III: A Simulation-Based Discussion of Design Strategies for Dose Optimization and Confirmatory Phase.
Clinical pharmacology and therapeutics·2026
Matching-adjusted indirect treatment comparisons in chronic inflammatory demyelinating polyneuropathy: interpreting current evidence and enhancing future studies.
Journal of comparative effectiveness research·2026
Epidemiology of medication-related problems and antimicrobial utilisation among critically ill cancer patients: Determinants, pharmacist interventions and clinical outcomes-A prospective observational study.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners·2026
Enhancing Cancer Immunotherapy with Berberine and Its Loaded Nanoparticles: A Systematic Review.
Anti-cancer agents in medicinal chemistry·2026